| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in RGNX over the last quarter tilts toward buying: insiders added a net 102,603 shares worth roughly $949K.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $3.78M | - | |
| CEO | 338.1K | $2.58M | - | |
| Other | 240.7K | $1.84M | - | |
| Other | 240.3K | $1.83M | - | |
| CFO | 147.1K | $1.12M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2018 | Curran Simpson64 | SVP, Technical Operations | Sale+OE | 62,309 | $60.85 | $3,791,502.65 | -61.2% | |
| Oct 16, 2018 | Stephen Yoo | Chief Medical Officer | Sale+OE | 20,414 | $60.28 | $1,230,540.52 | - | |
| Oct 15, 2018 | Kenneth T. Mills81 | President and CEO | Sell | 7,510 | $59.35 | $445,744.50 | -2.3% | |
| Oct 15, 2018 | Vittal Vasista79 | Chief Financial Officer | Sell | 7,500 | $59.37 | $445,275.00 | -5.2% | |
| Oct 8, 2018 | Olivier Danos | Chief Scientific Officer | Sale+OE | 20,000 | $63.80 | $1,275,913.92 | - | |
| Sep 17, 2018 | Kenneth T. Mills81 | President and CEO | Sell | 7,510 | $74.91 | $562,564.44 | -2.2% | |
| Sep 17, 2018 | Vittal Vasista79 | Chief Financial Officer | Sale+OE | 7,500 | $74.86 | $561,471.84 | -6.1% | |
| Aug 27, 2018 | Kenneth T. Mills81 | President and CEO | Sale+OE | 7,510 | $66.46 | $499,117.59 | -2.2% | |
| Aug 20, 2018 | Patrick J. Christmas | SVP, General Counsel | Sale+OE | 5,000 | $65.96 | $329,806.00 | -22.1% | |
| Aug 15, 2018 | Vittal Vasista79 | Chief Financial Officer | Sell | 7,500 | $65.43 | $490,709.68 | -5.8% |